Inventor · disambiguated record
Miles Stuart Congreve
Also filed as: CONGREVE MILES · CONGREVE MILES S · CONGREVE MILES STUART
95 granted patents·46 pending applications·870 citations·filing 1999–2025
99Inventor score
Files withHEPTARES THERAPEUTICS LTD72NXERA PHARMA UK LTD14ASTRAZENECA AB10ASTEX THERAPEUTICS LTD6CHESSARI GIANNI5
Top patents by PatentIndex Score
141 records- 0198US11352342B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Jun 7, 2022·9 cites·10 claims
- 0298US11014880B2Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted May 25, 2021·9 cites·13 claims
- 0398US10961225B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Mar 30, 2021·11 cites·16 claims
- 0498US9670183B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2015·Granted Jun 6, 2017·34 cites·23 claims
- 0597US11834407B2Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2021·Granted Dec 5, 2023·5 cites·13 claims
- 0697US10973832B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Apr 13, 2021·10 cites·16 claims
- 0797US10689368B2Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Jun 23, 2020·12 cites·20 claims
- 0897US10329278B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Jun 25, 2019·13 cites·17 claims
- 0997US10196380B2Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Feb 5, 2019·20 cites·16 claims
- 1096US11680053B2Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2021·Granted Jun 20, 2023·2 cites·22 claims
- 1196US11584732B2Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2021·Granted Feb 21, 2023·4 cites·17 claims
- 1296US11091456B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Aug 17, 2021·10 cites·20 claims
- 1396US11034704B2Muscarinic receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 1496US10981889B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Apr 20, 2021·5 cites·12 claims
- 1596US10759751B2Substituted spirocyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Sep 1, 2020·12 cites·18 claims
- 1696US10752610B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Aug 25, 2020·10 cites·20 claims
- 1796US10259787B2Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Apr 16, 2019·13 cites·8 claims
- 1896US9926297B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Mar 27, 2018·19 cites·18 claims
- 1996US9758506B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Sep 12, 2017·22 cites·20 claims
- 2096US7754725B2Dihydroxyphenyl isoindolymethanonesASTEX THERAPEUTICS LTD·Filed 2007·Granted Jul 13, 2010·22 cites·10 claims
- 2195US11999745B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2022·Granted Jun 4, 2024·3 cites·31 claims
- 2295US10548884B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Feb 4, 2020·11 cites·17 claims
- 2395US10385039B2Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Aug 20, 2019·13 cites·20 claims
- 2495US9907805B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Mar 6, 2018·15 cites·10 claims
- 2595US8106057B2Dihydroxyphenyl isoindolylmethanonesCHESSARI GIANNI·Filed 2010·Granted Jan 31, 2012·19 cites·7 claims
- 2694US10413553B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Sep 17, 2019·11 cites·8 claims
- 2794US10030035B2Muscarinic receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2015·Granted Jul 24, 2018·14 cites·17 claims
- 2894US9669013B2Bicyclic aza compounds as muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Jun 6, 2017·14 cites·18 claims
- 2994US9573929B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2015·Granted Feb 21, 2017·12 cites·4 claims
- 3094US9266857B2Bicyclic AZA compounds as muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2013·Granted Feb 23, 2016·23 cites·14 claims
- 3194US8685980B2Pyrrolopyrimidine compounds and their usesBESONG GILBERT EBAI·Filed 2009·Granted Apr 1, 2014·81 cites·15 claims
- 3294US7700625B2Hydroxybenzamide derivatives and their use as inhibitors of Hsp90ASTEX THERAPEUTICS LTD·Filed 2007·Granted Apr 20, 2010·25 cites·10 claims
- 3393US10428088B2Muscarinic receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Oct 1, 2019·11 cites·10 claims
- 3493US10351545B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Jul 16, 2019·10 cites·30 claims
- 3593US10246432B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Apr 2, 2019·9 cites·12 claims
- 3693US10167272B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Jan 1, 2019·11 cites·21 claims
- 3793US10112923B21,2,4-triazine-4-amine derivativesHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Oct 30, 2018·20 cites·3 claims
- 3893US9975890B2Bicyclic AZA compounds as muscarinic M1 receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted May 22, 2018·10 cites·9 claims
- 3993US9187451B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2012·Granted Nov 17, 2015·15 cites·14 claims
- 4092US10584111B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Mar 10, 2020·7 cites·15 claims
- 4192US10259802B2Bicyclic aza compounds as muscarinic M1 receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Apr 16, 2019·9 cites·20 claims
- 4292US8895745B2Bicyclic heterocyclic compounds as FGFR inhibitorsBERDINI VALERIO·Filed 2007·Granted Nov 25, 2014·33 cites·20 claims
- 4392US8101648B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90CHESSARI GIANNI·Filed 2006·Granted Jan 24, 2012·20 cites·18 claims
- 4491US11324738B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted May 10, 2022·9 cites·18 claims
- 4591US10167284B2Spirocyclic compounds as agonists of the muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Jan 1, 2019·12 cites·20 claims
- 4691US9676745B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2014·Granted Jun 13, 2017·10 cites·9 claims
- 4791US9593106B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2014·Granted Mar 14, 2017·20 cites·12 claims
- 4889US10166226B2CGRP receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Jan 1, 2019·3 cites·16 claims
- 4989US10030012B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Jul 24, 2018·9 cites·2 claims
- 5089US9925178B2CGRP receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Mar 27, 2018·4 cites·16 claims
Showing the top 50 of 141 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Miles Stuart Congreve files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →